ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
FDA workshop: Insights on inhaled antifungals and antibacterials
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Push! Pull! Push! Pull! / Highlights from Davos 2018
Impact of PASTEUR: 9.9m lives saved, ROI of 125:1
Developing antibiotics for children: There are no easy answers
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
Language matters: CRE vs. CPE; SDD vs. I; and MDR, XDR, PDR, UDR vs. DTR
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
FDA analysis of 40-years of antibacterial development: Dheman et al.
How hard (and how) to Pull? Net value of Pull via a Transferrable Exclusivity Extension (TEE)
Mirror Bacteria: An AMR threat of unprecedented magnitude
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet